One supermarket pill a day can prevent bowel cancer in people at high risk
Study shows lower dose aspirin works as expert warns 'too many people are missing out on a potentially life-changing opportunity to prevent cancer'
An aspirin a day can prevent bowel cancer in people at high risk of the disease, research has confirmed.
A new trial of 1,900 participants suggests GPs can recommend a low dose aspirin for people with the genetic condition Lynch syndrome. Higher doses of aspirin have previously been shown to prevent bowel cancer in this group but experts say GPs are still not advising it for these patients, partly due to concerns about the dosage.
Lead author Professor Sir John Burn, of Newcastle University, said: "Only a quarter of people with Lynch syndrome are currently taking aspirin. Too many people are missing out on a potentially life-changing opportunity to prevent cancer.'
'For 30 years, scientists have observed fewer cancers in people who take aspirin. This trial now tells us that aspirin can prevent bowel cancer at lower doses, minimising the chances of side-effects whilst offering vital protection for people with Lynch syndrome."
Lynch syndrome is a rare genetic condition that runs in families and one in 400 people in England have it - equivalent to around 175,000 people. Having Lynch syndrome substantially increases the risk of bowel cancer and increases the risk of other types of cancer, including womb, ovarian and prostate cancer.
The CaPP3 trial involved 1,879 people with Lynch syndrome in the UK, three other European countries and Australia who were treated with aspirin over five years. Participants on the trial were given three different doses of aspirin – 75-100mg, 300mg or 600mg a day – and received regular checks to see how they were doing throughout.
Case Study
Nick James, 46, a furniture maker from Gosforth in Newcastle, was the first to sign up to the CaPP3 trial in 2014. Nick decided to undergo genetic testing after his mum died from cancer, and other family members were diagnosed with bowel cancer. Tests showed he is a carrier for a faulty gene which causes Lynch syndrome.
Nick now has a colonoscopy every two years, continues to take aspirin, and remains cancer free. He said: 'Finding out I had a faulty gene that causes Lynch syndrome was extremely daunting, but taking part in this trial has given me hope that there is something that can reduce the chances of me and others developing cancer.
'It was fascinating to hear about how something as small as aspirin could potentially make such a big difference to my future. Taking three aspirin tablets a day wasn't hard, but it has helped this study and it could potentially help lots of people in the future.'
The trial found that those on the lowest aspirin dose did just as well as those on the higher doses, with fewer bowel cancers across all three doses. Aspirin given at lower doses is likely to cause fewer side-effects, including bleeding and stomach ulcers, than at higher doses.
Scientists leading the research are now in talks with the British National Formulary, used by all pharmacists and doctors, to update the advice it gives on aspirin.
Professor Burn added: 'We're now engaging with the regulators to change prescribing guidelines so that aspirin can be used more widely for people with a high risk of bowel cancer. We have a chance to give more people with Lynch syndrome protection which would reduce their fear of bowel cancer in the future.'
The National Institute of Health and Care Excellence (NICE) currently recommends that people with Lynch syndrome consider taking aspirin daily to prevent bowel cancer. But a survey carried out in 2016 revealed 47% of GPs were aware that they should recommend aspirin to people with Lynch syndrome and many were worried about the higher dose.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Record
11 hours ago
- Daily Record
UK tourists must apply for GHIC at least 15 days before flying to Europe
This free document allows Brits to access free or cheaper healthcare while abroad. Brits planning a European getaway this summer are being urged to secure an essential card at least 15 days before departure. This vital piece of documentation grants access to free or reduced-cost healthcare whilst overseas. The UK Global Health Insurance Card (GHIC), which took over from the widely recognised European Health Insurance Card (EHIC) in use since 2004, is a must-have for travellers. Although travel insurance remains a key recommendation for those holidaying abroad, the GHIC enables you to access public healthcare services across most European nations. The NHS website clarifies: "The UK Global Health Insurance Card (GHIC) lets you get necessary state healthcare in the European Economic Area (EEA), and some other countries, on the same basis as a resident of that country. This may be free or it may require a payment equivalent to that which a local resident would pay." For those who still possess a valid EHIC, it can be used until its expiry date. Post-expiry, a GHIC will be required as a replacement. Bear in mind that receiving a new GHIC by post typically takes up to 15 days, so it's wise to apply several weeks ahead of your intended travel dates. How to apply Eligibility for a free UK GHIC extends to UK residents, and applications can include family members. When applying, be prepared to provide: Your full name Your address Your date of birth Your National Insurance number Your Health and Care number (for Northern Ireland residents). Each family member requires an individual card. You have the option to include your spouse, civil partner, and offspring in your application all at once. Your personal information must be entered initially, followed by adding additional cards when prompted. Should you need to append further family members post-application, you ought to contact NHS Overseas Healthcare Services. Your reference number, full name, date of birth, and address are essentials for us to locate your details. Upon submission of your application, expect an email from the NHS within a day's time confirming its approval status - check your spam folder if no communication is received. The NHS may request supplementary information or documents to proceed with approval. In the event that your card does not arrive before travelling, and you require medical attention, apply for a Provisional Replacement Certificate (PRC) for interim coverage. What it covers The card enables access to state healthcare services during your stay that cannot be postponed until your return to the UK, often termed "medically necessary healthcare". This encompasses situations such as:. Emergency interventions and A&E attendance Management of chronic or pre-existing conditions Routine antenatal care provided giving birth abroad is not the purpose of your trip Certain treatments, such as kidney dialysis or chemotherapy, will need to be pre-arranged with the appropriate healthcare provider in the country you're visiting. This is due to the fact that it's not always guaranteed that local healthcare providers will have the capacity to provide this care. The decision on whether treatment is medically necessary is made by the healthcare provider in the country you're visiting. State healthcare isn't always free outside of the UK. You may be required to pay for treatments that would be free on the NHS if a local resident would be expected to pay in the country you're visiting. Before travelling, it's advisable to research the state-provided healthcare services in the country you're visiting and any potential charges you may face. You can check the relevant country guide on for information on how to access treatment in the country you're visiting. However, a GHIC (or EHIC) card does not replace travel and medical insurance or cover services like: Medical repatriation (being flown back to the UK) Treatment in a private medical facility Ski or mountain rescue For this reason, the NHS advises that you also have private travel and medical insurance for the duration of your trip. A UK GHIC can be used when you're visiting: A country in the European Economic Area (EEA) Montenegro Australia Jersey, Guernsey and the Isle of Man St Helena, Tristan and Ascension A UK GHIC can be used in Switzerland if you're one of the following:. A British national A Swiss national An EU citizen A refugee A stateless person A family member of someone who holds one of the above nationalities or statuses Article continues below The UK Government is in talks with various countries to broaden the applicability of the UK GHIC, so it's always advisable to verify coverage prior to your journey. For further details, visit the NHS website here.
Scottish Sun
18 hours ago
- Scottish Sun
Aspirin could be prescribed to prevent bowel cancer for those in high-risk group
Trial shows much smaller dose than previously recommended would work BIG C HOPE Aspirin could be prescribed to prevent bowel cancer for those in high-risk group Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) ASPIRIN could be prescribed to try to prevent bowel cancer for those in a high-risk group. A Cancer Research UK study found a small daily dose offers protection for people with Lynch syndrome. Sign up for Scottish Sun newsletter Sign up More than half of people with the genetic condition develop bowel cancer at some point in their life. Experts will apply for a prescription license to give 'baby' 75mg pills to the nearly 200,000 Brits with Lynch syndrome. CRUK said fewer than half of GPs knew they should prescribe aspirin to Lynch syndrome patients and many were worried about the dose size. The trial found a much smaller dose than the previously recommended 600mg would work, reducing the risk of side effects. Professor Sir John Burn, from Newcastle University, said: 'This tells us that aspirin can prevent bowel cancer at lower doses, minimising the chances of side-effects whilst offering vital protection for people with Lynch syndrome. 'Only a quarter of people with Lynch syndrome are currently taking aspirin and too many are missing out on a potentially life-changing opportunity to prevent cancer.' Lynch syndrome is estimated to cause about one in every 33 bowel cancer cases in the UK. Bowel tumours are one of the most common types, with 44,000 cases per year and 17,000 deaths. The 4 signs of bowel cancer that mean it's 'too late' - as doctor reveals cause of surge in young people being diagnosed 1 Aspirin could be prescribed to prevent bowel cancer for those in a high-risk group Credit: Getty
Daily Mirror
a day ago
- Daily Mirror
One supermarket pill a day can prevent bowel cancer in people at high risk
Study shows lower dose aspirin works as expert warns 'too many people are missing out on a potentially life-changing opportunity to prevent cancer' An aspirin a day can prevent bowel cancer in people at high risk of the disease, research has confirmed. A new trial of 1,900 participants suggests GPs can recommend a low dose aspirin for people with the genetic condition Lynch syndrome. Higher doses of aspirin have previously been shown to prevent bowel cancer in this group but experts say GPs are still not advising it for these patients, partly due to concerns about the dosage. Lead author Professor Sir John Burn, of Newcastle University, said: "Only a quarter of people with Lynch syndrome are currently taking aspirin. Too many people are missing out on a potentially life-changing opportunity to prevent cancer.' 'For 30 years, scientists have observed fewer cancers in people who take aspirin. This trial now tells us that aspirin can prevent bowel cancer at lower doses, minimising the chances of side-effects whilst offering vital protection for people with Lynch syndrome." Lynch syndrome is a rare genetic condition that runs in families and one in 400 people in England have it - equivalent to around 175,000 people. Having Lynch syndrome substantially increases the risk of bowel cancer and increases the risk of other types of cancer, including womb, ovarian and prostate cancer. The CaPP3 trial involved 1,879 people with Lynch syndrome in the UK, three other European countries and Australia who were treated with aspirin over five years. Participants on the trial were given three different doses of aspirin – 75-100mg, 300mg or 600mg a day – and received regular checks to see how they were doing throughout. Case Study Nick James, 46, a furniture maker from Gosforth in Newcastle, was the first to sign up to the CaPP3 trial in 2014. Nick decided to undergo genetic testing after his mum died from cancer, and other family members were diagnosed with bowel cancer. Tests showed he is a carrier for a faulty gene which causes Lynch syndrome. Nick now has a colonoscopy every two years, continues to take aspirin, and remains cancer free. He said: 'Finding out I had a faulty gene that causes Lynch syndrome was extremely daunting, but taking part in this trial has given me hope that there is something that can reduce the chances of me and others developing cancer. 'It was fascinating to hear about how something as small as aspirin could potentially make such a big difference to my future. Taking three aspirin tablets a day wasn't hard, but it has helped this study and it could potentially help lots of people in the future.' The trial found that those on the lowest aspirin dose did just as well as those on the higher doses, with fewer bowel cancers across all three doses. Aspirin given at lower doses is likely to cause fewer side-effects, including bleeding and stomach ulcers, than at higher doses. Scientists leading the research are now in talks with the British National Formulary, used by all pharmacists and doctors, to update the advice it gives on aspirin. Professor Burn added: 'We're now engaging with the regulators to change prescribing guidelines so that aspirin can be used more widely for people with a high risk of bowel cancer. We have a chance to give more people with Lynch syndrome protection which would reduce their fear of bowel cancer in the future.' The National Institute of Health and Care Excellence (NICE) currently recommends that people with Lynch syndrome consider taking aspirin daily to prevent bowel cancer. But a survey carried out in 2016 revealed 47% of GPs were aware that they should recommend aspirin to people with Lynch syndrome and many were worried about the higher dose.
